New Vaccine May Lead to Ground-breaking HIV Treatment

Armen Hareyan's picture
Advertisement

KANSAS CITY, Kan.- A University of Kansas School of Medicine researcher recently developed a DNA vaccine that is intended to take the place of expensive antiretroviral therapy for HIV patients. Bill Narayan, DVM, PhD, the principal investigator of a decades-long research project on studying HIV-like viruses, was awarded a $3 million grant from the National Institutes of Health to test the HIV vaccine on monkeys.

If these trials go well, he could receive more money to start clinical trials.

Advertisement